CTTI
@ctti_trials
Mission: Develop & drive adoption of practices that increase quality/efficiency of #ClinicalTrials. Follows/RTs ≠ endorsements #InnovationThroughCollaboration
ID: 755163601
http://www.ctti-clinicaltrials.org/ 13-08-2012 13:37:25
2,2K Tweet
2,2K Followers
606 Following
Our founder and CEO, Charles Fisher, was featured in an Endpoints News article covering yesterday's U.S. FDA/CTTI workshop on "Artificial Intelligence in Drug & Biological Product Development." 🚀 Read it here: endpts.com/fda-grapples-w…
Achieving representative clinical trials in the U.S. requires coordinated action. ACRP recognizes Multi-Regional Clinical Trials Center, CTTI, Milken Institute, and National Academies for developing a national plan to inspire system-level change in improving trial representation. bit.ly/3YAOOyO
Our CEO, Luca Emili, was a panelist at the U.S. FDA CTTI AI Workshop alongside Michael Lingzhi Li (Harvard Business School) and Subha Madhavan (Pfizer Inc.). Discover how we’re revolutionizing drug development! 🔗Read more here: linkedin.com/posts/insilico… #AI #FDA #DrugDevelopment
The FDA Patient Affairs and #CTTI PEC application process closed on August 8 at 11:59 p.m. ET. The application review process will take a minimum of two months. Thank you to all who applied to become a member! #patientengagement
Discover how Lindus Health revolutionized #clinicaltrials using #CTTI’s #AACT Database! From risk protection to #AI-driven protocol generation, learn about the transformative power of data-driven decisions in #clinicalresearch. bit.ly/LindusHealthcs
By leveraging #CTTI’s #AACT Database, Lindus Health drastically cut trial start-up times & improved outcome predictability. Explore their journey towards more efficient & robust #clinicaltrial designs. bit.ly/LindusHealthcs
“We went from protocol synopsis to first patient in 6 weeks!” Lindus Health’s use of #AACT Database sets a new standard in #clinicaltrials. Learn how data-driven insights can enhance trial success & speed. bit.ly/LindusHealthcs
Collaboration is key! Parent Project Muscular Dystrophy (PPMD)’s use of #CTTI’s Chevron Diagram has led to 7 #patient preference studies, proving that patient-centered research accelerates progress. Learn more at bit.ly/PPMDcs
Patient voices must be heard! Parent Project Muscular Dystrophy (PPMD) uses #CTTI tool to embed #patient insights across every stage of #Duchenne research, ensuring that drug development truly reflects what matters to patients. bit.ly/PPMDcs
Diverse clinical trials = better, more accurate research. #CTTI’s Sabrena Mervin-Blake sat down w/ Xtalks Webinars to talk strategies for boosting inclusivity in #clinicaltrials. From partnerships to accountability, here’s how CTTI is driving change. Read more: bit.ly/3B7poz5
Curious how we could transform clinical evidence generation to better align with #healthcare demands? A new paper by #CTTI, Duke Clinical Research Institute, Duke-Margolis & Protas explores approaches to modernizing #clinicaltrials infrastructure. Read more: bit.ly/47wqdxA BMC